Roku Inc  

(Public, NASDAQ:ROKU)   Watch this stock  
Find more results for ROKU
-9.05 (-17.71%)
After Hours: 42.25 +0.20 (0.48%)
Feb 22, 7:59PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.75 - 44.33
52 week 15.75 - 58.80
Open 40.39
Vol / Avg. 24.02M/4.33M
Mkt cap 4.11B
P/E     -
Div/yield     -
EPS -0.71
Shares 18.11M
Beta     -
Inst. own 58%

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -37.05% -10.73%
Operating margin -6.32% -10.88%
EBITD margin - -9.47%
Return on average assets -90.35% -24.05%
Return on average equity - -
Employees 696 -
CDP Score - -


150 Winchester Cir
LOS GATOS, CA 95032-1812
United States - Map
+1-408-5569040 (Phone)
+1-408-4462427 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Roku, Inc. operates television streaming platform. The Company connects users to streaming content, enables content publishers to build and monetize audiences and provides advertisers with capabilities to engage consumers. Its Roku platform allows users to personalize their content selection with cable television replacement offerings and other streaming services that suit their budget and needs. Ad-supported channels available on the Roku platform include CBS News, Crackle, The CW Television Network and Vice; subscription channels include HBO Now, Hulu and Netflix, as well as traditional pay TV replacement services like DirecTV Now, Sling TV and Sony PlayStation Vue; and transactional channels include Amazon Video, Google Play and Vudu. Its product categories include advertising, Roku TVs and Streaming Players.

Officers and directors

Anthony Wood Chief Executive Officer, Founder
Bio & Compensation  - Reuters
Steven Louden Chief Financial Officer
Bio & Compensation  - Reuters
Mark Goodwin Senior Vice President - Program Management
Bio & Compensation  - Reuters
Scott De Haas Senior Vice President - Product Engineering and Operations
Bio & Compensation  - Reuters
Matthew Anderson Chief Marketing Officer
Bio & Compensation  - Reuters